189 related articles for article (PubMed ID: 29914848)
1. Impact of rotavirus vaccines in Sub-Saharan African countries.
Mwenda JM; Parashar UD; Cohen AL; Tate JE
Vaccine; 2018 Nov; 36(47):7119-7123. PubMed ID: 29914848
[TBL] [Abstract][Full Text] [Related]
2. Using surveillance and economic data to make informed decisions about rotavirus vaccine introduction.
Cohen AL; Aliabadi N; Serhan F; Tate JE; Zuber P; Parashar UD
Vaccine; 2018 Dec; 36(51):7755-7758. PubMed ID: 30131194
[TBL] [Abstract][Full Text] [Related]
3. Health and economic impact of rotavirus vaccination in GAVI-eligible countries.
Kim SY; Sweet S; Slichter D; Goldie SJ
BMC Public Health; 2010 May; 10():253. PubMed ID: 20470426
[TBL] [Abstract][Full Text] [Related]
4. Rotavirus strain diversity in Eastern and Southern African countries before and after vaccine introduction.
Seheri LM; Magagula NB; Peenze I; Rakau K; Ndadza A; Mwenda JM; Weldegebriel G; Steele AD; Mphahlele MJ
Vaccine; 2018 Nov; 36(47):7222-7230. PubMed ID: 29203181
[TBL] [Abstract][Full Text] [Related]
5. Health Impact of Rotavirus Vaccination in Developing Countries: Progress and Way Forward.
Parashar UD; Johnson H; Steele AD; Tate JE
Clin Infect Dis; 2016 May; 62 Suppl 2():S91-5. PubMed ID: 27059361
[TBL] [Abstract][Full Text] [Related]
6. Introducing rotavirus vaccine in eight sub-Saharan African countries: a cost-benefit analysis.
Okafor CE; Ekwunife OI
Lancet Glob Health; 2021 Aug; 9(8):e1088-e1100. PubMed ID: 34297961
[TBL] [Abstract][Full Text] [Related]
7. Rotavirus vaccines: update on global impact and future priorities.
Yen C; Tate JE; Patel MM; Cortese MM; Lopman B; Fleming J; Lewis K; Jiang B; Gentsch J; Steele D; Parashar UD
Hum Vaccin; 2011 Dec; 7(12):1282-90. PubMed ID: 22108032
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.
Patel HD; Roberts ET; Constenla DO
Vaccine; 2013 Dec; 31(51):6072-8. PubMed ID: 24176497
[TBL] [Abstract][Full Text] [Related]
9. Evidence of rotavirus vaccine impact in sub-Saharan Africa: Systematic review and meta-analysis.
Godfrey O; Zhang W; Amponsem-Boateng C; Bonney Oppong T; Zhao Q; Li D
PLoS One; 2020; 15(4):e0232113. PubMed ID: 32339187
[TBL] [Abstract][Full Text] [Related]
10. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.
Atherly DE; Lewis KD; Tate J; Parashar UD; Rheingans RD
Vaccine; 2012 Apr; 30 Suppl 1():A7-14. PubMed ID: 22520139
[TBL] [Abstract][Full Text] [Related]
11. Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC.
Debellut F; Jaber S; Bouzya Y; Sabbah J; Barham M; Abu-Awwad F; Hjaija D; Ramlawi A; Pecenka C; Clark A; Mvundura M
PLoS One; 2020; 15(2):e0228506. PubMed ID: 32023295
[TBL] [Abstract][Full Text] [Related]
12. Impact of routine rotavirus vaccination on all-cause and rotavirus hospitalizations during the first four years following vaccine introduction in Rwanda.
Sibomana H; Rugambwa C; Mwenda JM; Sayinzoga F; Iraguha G; Uwimana J; Parashar UD; Tate JE
Vaccine; 2018 Nov; 36(47):7135-7141. PubMed ID: 29754701
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of rotavirus vaccination in children under five years of age in 195 countries: A meta-regression analysis.
Janko MM; Joffe J; Michael D; Earl L; Rosettie KL; Sparks GW; Albertson SB; Compton K; Pedroza Velandia P; Stafford L; Zheng P; Aravkin A; Kyu HH; Murray CJL; Weaver MR
Vaccine; 2022 Jun; 40(28):3903-3917. PubMed ID: 35643565
[TBL] [Abstract][Full Text] [Related]
14. Estimated reductions in hospitalizations and deaths from childhood diarrhea following implementation of rotavirus vaccination in Africa.
Shah MP; Tate JE; Mwenda JM; Steele AD; Parashar UD
Expert Rev Vaccines; 2017 Oct; 16(10):987-995. PubMed ID: 28832219
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda.
Tate JE; Ngabo F; Donnen P; Gatera M; Uwimana J; Rugambwa C; Mwenda JM; Parashar UD
Clin Infect Dis; 2016 May; 62 Suppl 2():S208-12. PubMed ID: 27059358
[TBL] [Abstract][Full Text] [Related]
16. Impact of rotavirus vaccine on rotavirus diarrhoea in countries of East and Southern Africa.
Weldegebriel G; Mwenda JM; Chakauya J; Daniel F; Masresha B; Parashar UD; Tate JE
Vaccine; 2018 Nov; 36(47):7124-7130. PubMed ID: 29102168
[TBL] [Abstract][Full Text] [Related]
17. Estimated impact and cost-effectiveness of rotavirus vaccination in Senegal: A country-led analysis.
Diop A; Atherly D; Faye A; Lamine Sall F; Clark AD; Nadiel L; Yade B; Ndiaye M; Fafa Cissé M; Ba M
Vaccine; 2015 May; 33 Suppl 1():A119-25. PubMed ID: 25919151
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of rotavirus vaccination in Ghana: Examining impacts from 2012 to 2031.
Nonvignon J; Atherly D; Pecenka C; Aikins M; Gazley L; Groman D; Narh CT; Armah G
Vaccine; 2018 Nov; 36(47):7215-7221. PubMed ID: 29223486
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of introducing universal childhood rotavirus vaccination in Bangladesh.
Sarker AR; Sultana M; Mahumud RA; Van Der Meer R; Morton A
Hum Vaccin Immunother; 2018 Jan; 14(1):189-198. PubMed ID: 29099653
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of rotavirus vaccination in Kenya and Uganda.
Sigei C; Odaga J; Mvundura M; Madrid Y; Clark AD; ;
Vaccine; 2015 May; 33 Suppl 1():A109-18. PubMed ID: 25919149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
